An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
VERDICT
The label
Markup
read at $153.01
Health Care Select Sector SPDR ETF holds its Markup at $153.01.
PHPhase · the trend structure carries the Markup label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · screen not yet scored
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger ·
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 4 days
Price
$153.01
Valuation
0.00 trailing · 0.00 forward price to earnings
Values screen
Not scored
Beta
N/A
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID
Read at
$153.01
0.00 P/E · 0.00 fwd
Price history & projections · where it has been, where the models see it going
Revenue growth
0.00%
Profit margin
0.00%
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This security has not been fully scored against the values screen yet.
Business activityIts core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending.Pass
ReceivablesMoney owed to the company is 0.0% of assets, under the 49% limit.Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Why it gives us pause
On our numbers, the price already runs ahead of the business.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
TRADE
Where & how to trade · wherever in the world you are
XLV trades on NYSE ARCA. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 4%. Entered 2026-08-18 · Markup
JOURNAL
The dated journal · newest first, never edited
2026-08-18Markup$153.01+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 4%.
2026-07-18Markup$153.01+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 4%.
2026-07-03Markup$153.01+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$153.01Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
POLITICAL
The political ledger · congressional disclosures
Disclosures naming XLV
Date
Politician
Party
Type
Amount
17 Dec2025
Tommy Tuberville
Republican
buy
15K–50K
17 Dec2025
Tommy Tuberville
Republican
buy
15K–50K
RETURNS
What holding actually paid · price plus dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$143.04
+6.9%
·
$1,069
+6.9%
2 months
$147.31
+3.8%
·
$1,038
+3.8%
3 months
$149.55
+2.2%
$0.60
$1,026
+2.6%
6 months
$152.30
+0.4%
$1.25
$1,012
+1.2%
1 year
$133.30
+14.7%
$2.51
$1,165
+16.5%
2 years
$142.10
+7.6%
$4.84
$1,110
+11.0%
3 years
$124.06
+23.2%
$7.05
$1,289
+28.9%
5 years
$114.91
+33.0%
$11.00
$1,426
+42.6%
Historical returns from market close data. Past performance does not guarantee future results.
SEALED
This entry now belongs to the ledger. Whatever XLV does next, these words stay.
Health Care Select Sector SPDR ETF · XLV · Markup · $153.01
Recorded · before the outcome · scored mechanically
